Publication:
MiT family translocation renal cell carcinomas: A 15th anniversary update.

Thumbnail Image
Files
Gandhi-35-125-136-2020.pdf(22.97 MB)
Date
2020
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Gandhi, atin S. ; Malik, Faizan ; Amin, Mahul B. ; Argani, Pedram ; Bahrami, Armita
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-159
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Microphthalmia (MiT) family translocation renal cell carcinomas (RCCs) are a heterogeneous category of renal tumors which all express MiT transcription factors, typically from chromosomal translocation and rarely from gene amplification. This tumor family has two major subtypes [i.e., Xp11 translocation RCC and t(6;11) RCC] and several related neoplasms (i.e., TFEB amplification RCC and melanotic Xp11 translocation renal cancers). Increased understanding of the clinical, pathological, molecular and prognostic heterogeneity of these tumors, since their official recognition in 2004, provides the opportunity to identify prognostic biomarkers and to understand the reasons for tumor aggression. We will review the literature from the past 15 years and highlight the need for a greater understanding of the molecular mechanisms underpinning heterogeneous tumor behavior
publication.page.subject
Renal cell carcinoma , Translocation renal cell carcinoma , TFE3 , TFEB
Citation
Histology and Histopathology Vol. 35, nº 2 (2020)
URI
http://hdl.handle.net/10201/125065
item.page.embargo
Collections
Histology and histopathology Vol.35, nº2 (2020)
Ir a Estadísticas